First Vaccine For Chikungunya—An Emerging Mosquito-Borne Threat—Nears After Promising Trial Results – Forbes

by

  1. First Vaccine For Chikungunya—An Emerging Mosquito-Borne Threat—Nears After Promising Trial Results Forbes
  2. First phase 3 trial of a chikungunya vaccine candidate finds it is generally safe and provokes an immune response Medical Xpress
  3. Safety and immunogenicity of a single-shot live-attenuated chikungunya vaccine: a double-blind, multicentre, randomised, placebo-controlled, phase 3 trial The Lancet
  4. Positive Results For Potential First Chikungunya Vaccine NDTV
  5. Phase-3 trials find 1-shot chikungunya vaccine safe, effective: Lancet timesofindia.com
  6. View Full Coverage on Google News

Read original article here

Leave a Comment